We are pioneers: inventors and developers of an entirely new class of therapeutics.
As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases.
Our long-term strategy leverages our in-house DARPin design and development expertise combined with the capabilities of world-class partners to deliver a broad pipeline of innovative therapeutics.
Wagistrasse 14, 8952 Schlieren – Switzerland
|Date||Trading entity / Person||Association||Trade type||Volume|
|15.02.22||None||Executive member||Sell||CHF 2,410,500.00|
|15.02.22||None||Executive member||Sell||CHF 1,607,000.00|
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.